These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29654436)

  • 1. Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany.
    Krone M; Dufner V; Wagner M; Gelbrich G; Ertl G; Heuschmann PU
    Clin Res Cardiol; 2018 Sep; 107(9):737-744. PubMed ID: 29654436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between disease burden and research funding through the Health Research Foundation in Spain].
    Gómez-García T; Moreno-Casbas T; González-María E; Fuentelsaz-Gallego C
    Enferm Clin; 2014; 24(4):219-32. PubMed ID: 24819151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research funding for rare diseases in Germany].
    Wissing F; Bruckner-Tuderman L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):550-555. PubMed ID: 28289776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health services research. A joint funding programme of the BMBF and GKV].
    Raspe H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Feb; 49(2):137-40. PubMed ID: 16391902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between research funding in the Spanish National Health System and the burden of disease].
    Catalá López F; Alvarez Martín E; Gènova Maleras R; Morant Ginestar C
    Rev Esp Salud Publica; 2009; 83(1):137-51. PubMed ID: 19495495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research funding of university medicine by the BMBF, DFG, and EU].
    Adler G; von dem Knesebeck J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Sep; 52(9):917-24. PubMed ID: 19693474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited alignment of publicly competitive disease funding with disease burden in Japan.
    Nomura S; Yoneoka D; Tanaka S; Makuuchi R; Sakamoto H; Ishizuka A; Nakamura H; Kubota A; Shibuya K
    PLoS One; 2020; 15(2):e0228542. PubMed ID: 32040510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent is health and medical research funding associated with the burden of disease in Australia?
    Aoun S; Pennebaker D; Pascal R
    Aust N Z J Public Health; 2004 Feb; 28(1):80-6. PubMed ID: 15108752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
    Carter AJ; Nguyen CN
    BMC Public Health; 2012 Jul; 12():526. PubMed ID: 22800364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing cutaneous research funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 Global Burden of Disease results.
    Karimkhani C; Boyers LN; Margolis DJ; Naghavi M; Hay RJ; Williams HC; Naldi L; Coffeng LE; Weinstock MA; Dunnick CA; Pederson H; Vos T; Murray CJ; Dellavalle RP
    PLoS One; 2014; 9(7):e102122. PubMed ID: 25003335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.
    Luengo-Fernandez R; Leal J; Gray A
    BMJ Open; 2015 Apr; 5(4):e006648. PubMed ID: 25869683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
    Luengo-Fernandez R; Leal J; Gray AM
    Eur J Neurol; 2012 Jan; 19(1):149-54. PubMed ID: 21951976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between funding by the National Institutes of Health and the burden of disease.
    Gross CP; Anderson GF; Powe NR
    N Engl J Med; 1999 Jun; 340(24):1881-7. PubMed ID: 10369852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research.
    Jung YL; Yoo HS; Kim ES
    Health Res Policy Syst; 2019 Dec; 17(1):103. PubMed ID: 31870382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
    Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
    Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.
    Begum M; Lewison G; Lawler M; Sullivan R
    Eur J Cancer; 2018 Sep; 100():75-84. PubMed ID: 30014883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.
    Schädlich PK; Brecht JG; Rangoonwala B; Huppertz E
    Pharmacoeconomics; 2004; 22(15):955-73. PubMed ID: 15449961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
    Head MG; Brown RJ; Clarke SC
    J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany.
    Stephani V; Sommariva S; Spranger A; Ciani O
    Health Res Policy Syst; 2017 Oct; 15(1):85. PubMed ID: 28969680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden.
    Hagstrom EL; Patel S; Karimkhani C; Boyers LN; Williams HC; Hay RJ; Weinstock MA; Armstrong AW; Dunnick CA; Margolis DJ; Dellavalle RP
    J Am Acad Dermatol; 2015 Sep; 73(3):383-91.e1. PubMed ID: 26051697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.